Boston Scientific choose Antonini Urology as Italian Center of Excellence for Penile Prosthesis Implants

Rome, May 2023 – Boston Scientific, one of the leading companies in the medical technology sector, has selected the Antonini Institute as the Italian Center of Excellence for penile prosthesis implants. This recognition testifies to Antonini’s expertise and experience in the treatment of male sexual dysfunctions and underscores the importance of the European market for the American company.
Boston Scientific has long been committed to developing innovative solutions for the treatment of male sexual dysfunctions, including penile prosthesis implants. The choice of Antonini as the Center of Excellence for Italy represents a significant step forward in the company’s expansion strategy in the European market.
Antonini Urology is known for its excellence in the diagnosis and treatment of male sexual dysfunctions. The center has a multidisciplinary team of experts, including urologists, andrologists, psychologists, and physiotherapists specialized in male sexual health. This collaboration with Boston Scientific will further consolidate Antonini’s position as a reference point for penile implantology in Italy and Europe.
The partnership between Boston Scientific and Antonini will bring numerous benefits to patients with male sexual dysfunctions. Thanks to the experience of both organizations, patients will have access to cutting-edge solutions to improve their quality of life and restore sexual function. Penile prosthesis implants represent an effective and long-lasting treatment for patients who do not respond to other non-invasive therapies.
Boston Scientific’s decision to recognize Antonini as the Italian Center of Excellence for penile prosthesis implants underscores the strategic importance of Europe as a key market for the company. The partnership will expand the reach of Boston Scientific’s solutions in the treatment of male sexual dysfunctions and offer greater accessibility to patients across Europe.
The choice of Antonini as the Italian Center of Excellence for penile prosthesis implants represents a significant development in the medical technology sector. The collaboration with Boston Scientific confirms Antonini’s reputation as a leader in the diagnosis and treatment of male sexual dysfunctions. Through this partnership, patients will have access to advanced treatments that will improve their quality of life and restore sexual function. Furthermore, Boston Scientific’s expansion into the European market highlights the growing importance of Europe as a hub for innovation and development in the medical field.